124 related articles for article (PubMed ID: 7275343)
1. Concomitant renal and hepatic failure treated by polyacrylonitrile membrane hemodialysis.
Strand V; Mayor G; Ristow G; Greenbaum D; Mayle J; Rosenbaum R
Int J Artif Organs; 1981 May; 4(3):136-9. PubMed ID: 7275343
[TBL] [Abstract][Full Text] [Related]
2. Clearances and solutes extraction in biofiltration and hemodialysis with the AN 69 S.
Bertoli S; Genderini A; Barone MT; Scorza D; Barbiano di Belgiojoso G; Cabrini E
Int J Artif Organs; 1986 Dec; 9 Suppl 3():121-2. PubMed ID: 3557659
[TBL] [Abstract][Full Text] [Related]
3. Efficiency of different hollow-fiber hemofilters in continuous arteriovenous hemodiafiltration.
Morabito S; Pierucci A; Marinelli R; Cicciarelli A; Guzzo I; Cinotti GA; Marino B; Chiavarelli R
Am J Nephrol; 2000; 20(2):116-21. PubMed ID: 10773611
[TBL] [Abstract][Full Text] [Related]
4. Biocompatible membranes in acute renal failure.
Shaldon S
Lancet; 1996 Jan; 347(8995):205-6. PubMed ID: 8544586
[No Abstract] [Full Text] [Related]
5. Haemodialysis in the treatment of lactic acidosis associated with acute hepatic and renal failure.
Colombi A; Thölen H
Postgrad Med J; 1971 Sep; 47(551):628-31. PubMed ID: 5098925
[No Abstract] [Full Text] [Related]
6. Experiences in the treatment of fulminant hepatic failure by conservative therapy, charcoal haemoperfusion, and polyacrylonitrile haemodialysis.
Silk DB; Williams R
Int J Artif Organs; 1978 Jan; 1(1):29-33. PubMed ID: 669832
[No Abstract] [Full Text] [Related]
7. Membrane biocompatibility in the treatment of acute renal failure: what is the evidence in 1996?
Jacobs C
Nephrol Dial Transplant; 1997 Jan; 12(1):38-42. PubMed ID: 9027771
[No Abstract] [Full Text] [Related]
8. The effects of hemodialysis with different membranes on middle molecules and uremic neuropathy.
Djukanović LJ; Mimić-Oka JI; Potić JB
Int J Artif Organs; 1989 Jan; 12(1):11-9. PubMed ID: 2538398
[TBL] [Abstract][Full Text] [Related]
9. [Artificial hepatic support device with polyacrylonitrile (PAN) membrane, with special reference to hemodiafiltration].
Sakai K; Suzuki M; Hirasawa Y; Ichida F
Nihon Rinsho; 1982; 40(4):890-6. PubMed ID: 7098060
[No Abstract] [Full Text] [Related]
10. Is the choice of membrane important for patients with acute renal failure requiring hemodialysis?
Splendiani G; Mazzarella V
Artif Organs; 1996 Mar; 20(3):281. PubMed ID: 8694703
[No Abstract] [Full Text] [Related]
11. Plasma amino acid profiles in patients with fulminant hepatic failure treated by repeated polyacrylonitrile membrane hemodialysis.
Chase RA; Davies M; Trewby PN; Silk DB; Williams R
Gastroenterology; 1978 Dec; 75(6):1033-40. PubMed ID: 710854
[No Abstract] [Full Text] [Related]
12. Hemodialysis versus cross hemodialysis in experimental hepatic coma.
Opolon P; Lavallard MC; Huguet C; Bidallier M; Granger A; Gallot D; Bloch P
Surg Gynecol Obstet; 1976 Jun; 142(6):845-53. PubMed ID: 936027
[TBL] [Abstract][Full Text] [Related]
13. Hepatic failure coma (HFC) treated by polyacrylonitrile membrane (PAN) hemodialysis (HD).
Opolon P; Rapin JR; Huguet C; Granger A; Delorme ML; Boschat M; Sausse A
Trans Am Soc Artif Intern Organs; 1976; 22():701-10. PubMed ID: 781986
[No Abstract] [Full Text] [Related]
14. Anaphylactoid reactions during hemodialysis on AN69 membranes in patients receiving ACE inhibitors.
Tielemans C; Madhoun P; Lenaers M; Schandene L; Goldman M; Vanherweghem JL
Kidney Int; 1990 Nov; 38(5):982-4. PubMed ID: 2266684
[TBL] [Abstract][Full Text] [Related]
15. Treatment of fulminant hepatic failure by polyacrylonitrile-membrane haemodialysis.
Silk DB; Trewby PN; Chase RA; Mellon PJ; Hanid MA; Davies M; Langley PG; Wheeler PG; Williams R
Lancet; 1977 Jul; 2(8027):1-3. PubMed ID: 69100
[TBL] [Abstract][Full Text] [Related]
16. Is platelet-activating factor produced during hemodialysis with AN-69 polyacrylonitrile membrane?
Iatrou C; Afentakis N; Nomikos T; Dinas C; Stavropoulos-Giokas C; Antonopoulou S
Nephron; 2002 May; 91(1):86-93. PubMed ID: 12021524
[TBL] [Abstract][Full Text] [Related]
17. Patient survival on PAN/AN69 membrane hemodialysis: a ten-year analysis.
Chandran PK; Liggett R; Kirkpatrick B
J Am Soc Nephrol; 1993 Nov; 4(5):1199-204. PubMed ID: 8305647
[TBL] [Abstract][Full Text] [Related]
18. Lowering plasma levels of complement factor D with AN69 dialysis membranes.
Strobel WM; Gürke T; Schifferli JA
J Clin Apher; 1999; 14(4):188-9. PubMed ID: 10611630
[No Abstract] [Full Text] [Related]
19. [Beneficial effect of AN69 membranes on anemia in hemodialyzed patients].
García Cortés MJ; Sánchez Perales MC; Liébana A; Gil JM; Borrego FJ; Borrego J; Pérez del Barrio P; Serrano P; Pérez Bañasco V
Nefrologia; 2001; 21(4):370-5. PubMed ID: 11816513
[TBL] [Abstract][Full Text] [Related]
20. [Mechanisms of acute leukopenia in hemodialysis. Role of direct leukocyte and dialyzer membrane interaction].
Pacitti A; Segoloni G; Triolo G; Tetta C; Messina M; Bussolino F; Camussi G; Ragni R; Martini PF; Coppo R; Vercellone A
Minerva Nefrol; 1980; 27(4):651-3. PubMed ID: 7254693
[No Abstract] [Full Text] [Related]
[Next] [New Search]
